Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 70/100

Clinical trial data shows RAD 101 detects Brain Metastases

Monday, February 10, 2025 1 min read
Key Takeaway: Recent clinical trial data reveals that RAD 101 effectively detects brain metastases. This promising development could enhance diagnostic capabilities in oncology, potentially leading to better patient management. The findings underscore the importance of RAD 101 in the evolving landscape of cancer treatment.
Price reaction · baseline $4.9 (2025-02-07 close) · hit pre-market · clean, no other RADX news in the window
day 0 close · peak
-4.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • RAD 101 shows promise in detecting brain metastases.
  • The clinical trial data indicates effective results.
  • Potential for improved patient outcomes in oncology.

Full Press Release Details

• Announcements
• Price Sensitive
• February 10, 2025
Loading Viewer…

More Announcements & Updates

• Announcements
• January 24, 2022
• Announcements
• June 25, 2024
• Announcements
• March 28, 2023
• Announcements
• September 30, 2024

Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)

Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

• RAD Presentation June 2026
• Zacks Small-Cap Research 2026
• RAD Presentation March 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research

Frequently Asked Questions

What is RAD 101 used for?

RAD 101 is used for detecting brain metastases.

What were the results of the clinical trial?

The clinical trial data shows that RAD 101 effectively detects brain metastases.

Who developed RAD 101?

RAD 101 is developed by Radiopharm Theranostics.

What is the significance of RAD 101's findings?

The findings could improve diagnostic capabilities in oncology.

Tags: RADX Viatris Investor Conferences Healthcare RAD 101 brain metastases clinical trial oncology Radiopharm Theranostics
Last updated: Feb 10, 2025